Free Trial

TherapeuticsMD (TXMD) Short Interest Ratio & Short Volume

TherapeuticsMD logo
$1.37 +0.04 (+3.01%)
(As of 11/22/2024 ET)

TherapeuticsMD Short Interest Data

TherapeuticsMD (TXMD) has a short interest of 29,700 shares, representing 0.26% of the float (the number of shares available for trading by the public). This marks a 26.38% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 22,845 shares to cover all short positions.

Current Short Interest
29,700 shares
Previous Short Interest
23,500 shares
Change Vs. Previous Month
+26.38%
Dollar Volume Sold Short
$46,035.00
Short Interest Ratio
2.2 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
11,530,000 shares
Float Size
11,340,000 shares
Short Percent of Float
0.26%
Today's Trading Volume
25,024 shares
Average Trading Volume
22,845 shares
Today's Volume Vs. Average
110%
Short Selling TherapeuticsMD?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TXMD Short Interest Over Time

TXMD Days to Cover Over Time

TXMD Percentage of Float Shorted Over Time

TherapeuticsMD Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202429,700 shares $46,035.00 +26.4%0.3%2.2 $1.55
10/15/202423,500 shares $35,893.90 -6.4%0.2%1.7 $1.53
9/30/202425,100 shares $41,666.00 -72.5%0.2%1.8 $1.66
9/15/202491,300 shares $163,417.87 -8.4%0.8%5.7 $1.79
8/31/202499,700 shares $187,934.50 -12.1%0.9%5.9 $1.89
8/15/2024113,400 shares $182,574.00 +172.6%1.0%6.6 $1.61
7/31/202441,600 shares $72,800.00 -2.4%0.4%2.6 $1.75
7/15/202442,600 shares $77,106.00 -19.6%0.4%2.6 $1.81
6/30/202453,000 shares $85,330.00 +57.7%0.5%2.7 $1.61
6/15/202433,600 shares $68,208.00 -7.7%0.3%1.8 $2.03
5/31/202436,400 shares $80,808.00 -7.4%0.3%1.9 $2.22
5/15/202439,300 shares $82,137.00 -23.2%0.4%1.7 $2.09
4/30/202451,200 shares $96,256.00 +11.6%0.5%2.3 $1.88
4/15/202445,900 shares $89,505.00 +1.6%0.4%2 $1.95
3/31/202445,200 shares $103,508.00 -4.6%0.4%2.1 $2.29
3/15/202447,400 shares $113,760.00 +15.9%0.5%2.4 $2.40
2/29/202440,900 shares $98,160.00 -18.9%0.4%1.8 $2.40
2/15/202450,400 shares $112,896.00 -8.2%0.5%2.6 $2.24
1/31/202454,900 shares $124,074.00 -57.7%0.5%2.5 $2.26
1/15/2024129,800 shares $295,944.00 -39.8%1.3%5.6 $2.28
12/31/2023215,600 shares $485,100.00 +143.1%N/A9.3 $2.25
12/15/202388,700 shares $207,558.00 -56.8%0.9%3.9 $2.34
11/30/2023205,400 shares $529,932.00 -4.1%2.0%9.4 $2.58
11/15/2023214,100 shares $505,276.00 -13.8%2.1%10.7 $2.36
10/31/2023248,500 shares $529,305.00 +162.4%2.4%13.1 $2.13
10/15/202394,700 shares $240,538.00 -8.7%0.9%4.8 $2.54
9/30/2023103,700 shares $313,174.00 -71.9%1.1%5.4 $3.02
9/15/2023369,000 shares $1.23 million +21.3%3.8%18.2 $3.33
8/31/2023304,300 shares $1.15 million -5.1%3.1%13.2 $3.79
8/15/2023320,700 shares $1.23 million -4.7%3.3%13.1 $3.84
7/31/2023336,400 shares $1.37 million -7.9%3.6%11.4 $4.06
7/15/2023365,100 shares $1.43 million +0.3%3.9%11.1 $3.93
6/30/2023364,200 shares $1.50 million +21.4%3.9%10.2 $4.12
6/15/2023300,100 shares $1.15 million +1.7%3.2%8 $3.84
5/31/2023295,100 shares $1.22 million -5.6%3.1%7.8 $4.15
5/15/2023312,600 shares $1.37 million -8.7%3.3%8.1 $4.39
4/30/2023342,400 shares $1.21 million +3.5%3.7%10 $3.54
4/15/2023330,900 shares $1.20 million +4.3%3.6%8.8 $3.62
3/31/2023317,200 shares $1.19 million +20.2%3.4%8 $3.75
3/15/2023263,800 shares $962,870.00 +10.4%3.0%5.5 $3.65
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

2/28/2023239,000 shares $1.19 million -11.2%2.7%1.9 $4.96
2/15/2023269,000 shares $1.38 million -5.4%3.2%2.1 $5.13
1/31/2023284,400 shares $1.50 million -12.1%3.2%2.1 $5.27
1/15/2023323,500 shares $1.75 million -4.1%3.8%2.4 $5.40
12/30/2022337,200 shares $1.88 million -26.2%4.0%2.5 $5.59
12/15/2022457,000 shares $3.03 million +46.8%5.4%3.4 $6.63
11/30/2022311,300 shares $1.43 million -19.5%3.7%2.4 $4.58
11/15/2022386,500 shares $2.29 million +12.9%4.6%5.4 $5.93
10/31/2022342,400 shares $2.17 million +2.4%4.1%2.7 $6.33
10/15/2022334,400 shares $2.15 million -3.3%4.0%1.2 $6.44
9/30/2022345,900 shares $2.30 million -5.9%4.2%0.8 $6.64
9/15/2022367,600 shares $2.87 million -11.2%4.4%0.6 $7.80
8/31/2022413,800 shares $4.10 million -33.3%5.0%0.5 $9.91
8/15/2022620,700 shares $5.74 million -32.6%8.0%0.6 $9.24
7/31/2022921,100 shares $5.74 million +38.6%11.9%0.6 $6.23
7/15/2022664,500 shares $3.95 million +65.7%8.6%0.5 $5.94
6/30/2022401,000 shares $3.99 million -28.3%5.2%0.3 $9.95
6/15/2022559,600 shares $5.55 million -72.2%7.4%0.5 $9.92
5/31/20222,010,000 shares $19.96 million +36.7%26.4%2.2 $9.93
5/15/20221,470,000 shares $4.51 million +94.1%19.3%2.2 $3.07
4/30/2022757,300 shares $7.64 million -97.6%10.0%4.3 $10.09
4/15/202231,900,000 shares $9.25 million +2.8%8.4%4.5 $0.29
3/31/202231,030,000 shares $11.79 million -2.6%8.2%4.7 $0.38
3/15/202231,870,000 shares $10.37 million +28.6%N/A4.1 $0.33
2/28/202224,790,000 shares $5.93 million -2.4%N/A3.3 $0.24
2/15/202225,410,000 shares $6.68 million +11.6%N/A3.8 $0.26
1/31/202222,760,000 shares $6.92 million -10.2%N/A3.4 $0.30
1/15/202225,350,000 shares $8.75 million +35.2%N/A4.1 $0.35
12/31/202118,750,000 shares $6.67 million -29.4%N/A3.2 $0.36
12/15/202126,550,000 shares $10.78 million -20.0%N/A5.7 $0.41
11/30/202133,180,000 shares $16.42 million +9.9%N/A6.9 $0.50
11/15/202130,180,000 shares $18.50 million +3.6%N/A7 $0.61
10/29/202129,130,000 shares $21.21 million +2.5%N/A6.3 $0.73
10/15/202128,430,000 shares $20.49 million -1.6%N/A5.7 $0.72
9/30/202128,890,000 shares $21.42 million +0.7%N/A5.6 $0.74
9/15/202128,680,000 shares $20.74 million +24.4%N/A4.8 $0.72
8/31/202123,060,000 shares $18.33 million +2.1%5.9%4.1 $0.80
8/13/202122,580,000 shares $19.45 million -30.2%N/A4 $0.86
7/30/202132,340,000 shares $32.34 million -4.9%N/A5.9 $1.00
7/15/202134,000,000 shares $35.02 million -39.3%9.3%5.4 $1.03
6/30/202156,000,000 shares $66.64 million -1.1%15.3%8 $1.19
6/15/202156,620,000 shares $71.34 million -5.1%15.4%8 $1.26
5/28/202159,670,000 shares $72.20 million -3.8%16.3%7 $1.21
5/14/202162,040,000 shares $65.76 million -4.1%N/A5.9 $1.06
4/30/202164,690,000 shares $72.45 million +0.0%N/A4.4 $1.12
4/15/202164,670,000 shares $78.90 million +8.3%N/A4.2 $1.22
3/31/202159,720,000 shares $80.02 million +3.7%N/A4 $1.34
3/15/202157,570,000 shares $91.54 million +3.3%N/A4 $1.59
2/26/202155,740,000 shares $85.84 million -23.3%N/A4.2 $1.54
2/12/202172,670,000 shares $139.53 million +11.0%N/A6.5 $1.92
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

1/29/202165,500,000 shares $104.15 million -0.8%N/A8.1 $1.59
1/15/202166,050,000 shares $95.11 million -14.1%N/A11.9 $1.44
12/31/202076,900,000 shares $92.28 million -2.9%N/A16.8 $1.20
12/15/202079,220,000 shares $91.10 million -4.4%N/A19.2 $1.15
11/30/202082,850,000 shares $113.50 million +0.3%N/A24.5 $1.37
11/15/202082,630,000 shares $101.63 million -0.8%N/A27.7 $1.23
10/30/202083,290,000 shares $109.94 million -2.0%34.9%31.4 $1.32
10/15/202085,000,000 shares $136 million -0.9%35.7%28.9 $1.60
9/30/202085,730,000 shares $135.45 million -1.1%36.0%22.7 $1.58
9/15/202086,680,000 shares $116.15 million -2.2%36.4%21.5 $1.34
8/31/202088,660,000 shares $129.44 million -0.3%37.2%19.8 $1.46
8/14/202088,910,000 shares $148.48 million +4.1%37.4%17.3 $1.67
7/31/202085,450,000 shares $158.08 million +3.0%35.9%15.8 $1.85
7/15/202082,960,000 shares $123.61 million +0.1%34.9%13.9 $1.49
6/30/202082,860,000 shares $103.58 million -0.2%34.9%14.8 $1.25
6/15/202082,990,000 shares $108.72 million +0.8%35.0%15.3 $1.31
5/29/202082,340,000 shares $93.04 million +0.4%34.7%15.3 $1.13
5/15/202082,020,000 shares $95.96 million +0.7%34.5%16.3 $1.17
4/30/202081,420,000 shares $128.64 million -4.4%34.3%16.1 $1.58
4/15/202085,200,000 shares $74.04 million -4.0%35.9%20.9 $0.87
3/31/202088,780,000 shares $81.68 million -5.8%37.4%21.9 $0.92
3/13/202094,253,800 shares $96.14 million +4.0%39.7%26.1 $1.02
2/28/202090,620,000 shares $88.81 million -0.4%38.2%23.1 $0.98
2/14/202090,950,000 shares $146.43 million +0.0%38.3%24 $1.61
1/31/202090,930,000 shares $161.86 million +6.5%38.4%25.8 $1.78
1/15/202085,400,000 shares $221.19 million -1.6%36.0%21.2 $2.59
12/31/201986,820,000 shares $215.31 million +9.4%36.6%23.7 $2.48

TXMD Short Interest - Frequently Asked Questions

What is TherapeuticsMD's current short interest?

Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 29,700 shares of TXMD short. 0.26% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest.

What is a good short interest ratio for TherapeuticsMD?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXMD shares currently have a short interest ratio of 2.0. Learn More on TherapeuticsMD's short interest ratio.

What is a good short interest percentage for TherapeuticsMD?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of TherapeuticsMD's floating shares are currently sold short.

Is TherapeuticsMD's short interest increasing or decreasing?

TherapeuticsMD saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 29,700 shares, an increase of 26.4% from the previous total of 23,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TherapeuticsMD's float size?

TherapeuticsMD currently has issued a total of 11,532,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 11,340,000 shares.

How does TherapeuticsMD's short interest compare to its competitors?

0.26% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies compare to TherapeuticsMD: InterCure Ltd. (0.05%), Atara Biotherapeutics, Inc. (16.03%), CervoMed Inc. (27.66%), OptiNose, Inc. (5.68%), Entera Bio Ltd. (0.12%), Mural Oncology plc (2.62%), Aadi Bioscience, Inc. (1.57%), Aileron Therapeutics, Inc. (1.19%), Theratechnologies Inc. (0.23%), Kezar Life Sciences, Inc. (2.87%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short TherapeuticsMD stock?

Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TXMD shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TherapeuticsMD?

A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further.

How often is TherapeuticsMD's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:TXMD) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners